Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VICL (Vical Labs) -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (1106)	8/3/1999 12:39:00 AM
From: Greg Rich	Read Replies (1) \| Respond to of 1972

Just a quick note about your comment that VICL "is also a McCamant pick." For what it's worth, Jim McCamant does not currently include VICL in his list of recommended companies. I was told on the phone a couple of months ago that he has no plans of adding VICL to his list. greg

To: Mike McFarland who wrote (1106)	8/3/1999 9:54:00 AM
From: D. Chapman	Respond to of 1972

Dear Mike, please give me until Thurs. evening for my response... I've got final exams this week, and will be done Thurs., upon which I will happy to give both my analysis of the technology as well as of the financials... wrt latter, I've noticed how "creative" financing involving future dilutions and/or floating rates can have very detrimental effects on the stock price, irrespective of the technology... I don't know the financial details, but will be happy to critique the tech./financials Thurs.